IBDEI1F3 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22924,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
;;^UTILITY(U,$J,358.3,22924,1,4,0)
;;=4^C85.16
;;^UTILITY(U,$J,358.3,22924,2)
;;=^5001707
;;^UTILITY(U,$J,358.3,22925,0)
;;=C85.12^^76^987^7
;;^UTILITY(U,$J,358.3,22925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22925,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
;;^UTILITY(U,$J,358.3,22925,1,4,0)
;;=4^C85.12
;;^UTILITY(U,$J,358.3,22925,2)
;;=^5001703
;;^UTILITY(U,$J,358.3,22926,0)
;;=C85.14^^76^987^1
;;^UTILITY(U,$J,358.3,22926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22926,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
;;^UTILITY(U,$J,358.3,22926,1,4,0)
;;=4^C85.14
;;^UTILITY(U,$J,358.3,22926,2)
;;=^5001705
;;^UTILITY(U,$J,358.3,22927,0)
;;=C85.11^^76^987^3
;;^UTILITY(U,$J,358.3,22927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22927,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
;;^UTILITY(U,$J,358.3,22927,1,4,0)
;;=4^C85.11
;;^UTILITY(U,$J,358.3,22927,2)
;;=^5001702
;;^UTILITY(U,$J,358.3,22928,0)
;;=C85.15^^76^987^4
;;^UTILITY(U,$J,358.3,22928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22928,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
;;^UTILITY(U,$J,358.3,22928,1,4,0)
;;=4^C85.15
;;^UTILITY(U,$J,358.3,22928,2)
;;=^5001706
;;^UTILITY(U,$J,358.3,22929,0)
;;=C85.18^^76^987^8
;;^UTILITY(U,$J,358.3,22929,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22929,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
;;^UTILITY(U,$J,358.3,22929,1,4,0)
;;=4^C85.18
;;^UTILITY(U,$J,358.3,22929,2)
;;=^5001709
;;^UTILITY(U,$J,358.3,22930,0)
;;=C85.17^^76^987^9
;;^UTILITY(U,$J,358.3,22930,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22930,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Spleen
;;^UTILITY(U,$J,358.3,22930,1,4,0)
;;=4^C85.17
;;^UTILITY(U,$J,358.3,22930,2)
;;=^5001708
;;^UTILITY(U,$J,358.3,22931,0)
;;=C85.10^^76^987^10
;;^UTILITY(U,$J,358.3,22931,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22931,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Unspec Site
;;^UTILITY(U,$J,358.3,22931,1,4,0)
;;=4^C85.10
;;^UTILITY(U,$J,358.3,22931,2)
;;=^5001701
;;^UTILITY(U,$J,358.3,22932,0)
;;=L60.1^^76^988^2
;;^UTILITY(U,$J,358.3,22932,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22932,1,3,0)
;;=3^Onycholysis
;;^UTILITY(U,$J,358.3,22932,1,4,0)
;;=4^L60.1
;;^UTILITY(U,$J,358.3,22932,2)
;;=^186837
;;^UTILITY(U,$J,358.3,22933,0)
;;=L60.2^^76^988^1
;;^UTILITY(U,$J,358.3,22933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22933,1,3,0)
;;=3^Onychogryphosis
;;^UTILITY(U,$J,358.3,22933,1,4,0)
;;=4^L60.2
;;^UTILITY(U,$J,358.3,22933,2)
;;=^5009235
;;^UTILITY(U,$J,358.3,22934,0)
;;=B35.1^^76^988^3
;;^UTILITY(U,$J,358.3,22934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22934,1,3,0)
;;=3^Onychomycosis
;;^UTILITY(U,$J,358.3,22934,1,4,0)
;;=4^B35.1
;;^UTILITY(U,$J,358.3,22934,2)
;;=^119748
;;^UTILITY(U,$J,358.3,22935,0)
;;=L60.3^^76^988^4
;;^UTILITY(U,$J,358.3,22935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22935,1,3,0)
;;=3^Onychorrexis/Onychodystrophy
;;^UTILITY(U,$J,358.3,22935,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,22935,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,22936,0)
;;=L50.8^^76^989^4
;;^UTILITY(U,$J,358.3,22936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22936,1,3,0)
;;=3^Urticaria,Other Spec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1F3 3761 printed Apr 09, 2024@21:10:08 Page 2
IBDEI1F3 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22924,1,3,0)
+2 ;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
+3 ;;^UTILITY(U,$J,358.3,22924,1,4,0)
+4 ;;=4^C85.16
+5 ;;^UTILITY(U,$J,358.3,22924,2)
+6 ;;=^5001707
+7 ;;^UTILITY(U,$J,358.3,22925,0)
+8 ;;=C85.12^^76^987^7
+9 ;;^UTILITY(U,$J,358.3,22925,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,22925,1,3,0)
+12 ;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
+13 ;;^UTILITY(U,$J,358.3,22925,1,4,0)
+14 ;;=4^C85.12
+15 ;;^UTILITY(U,$J,358.3,22925,2)
+16 ;;=^5001703
+17 ;;^UTILITY(U,$J,358.3,22926,0)
+18 ;;=C85.14^^76^987^1
+19 ;;^UTILITY(U,$J,358.3,22926,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,22926,1,3,0)
+22 ;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
+23 ;;^UTILITY(U,$J,358.3,22926,1,4,0)
+24 ;;=4^C85.14
+25 ;;^UTILITY(U,$J,358.3,22926,2)
+26 ;;=^5001705
+27 ;;^UTILITY(U,$J,358.3,22927,0)
+28 ;;=C85.11^^76^987^3
+29 ;;^UTILITY(U,$J,358.3,22927,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,22927,1,3,0)
+32 ;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
+33 ;;^UTILITY(U,$J,358.3,22927,1,4,0)
+34 ;;=4^C85.11
+35 ;;^UTILITY(U,$J,358.3,22927,2)
+36 ;;=^5001702
+37 ;;^UTILITY(U,$J,358.3,22928,0)
+38 ;;=C85.15^^76^987^4
+39 ;;^UTILITY(U,$J,358.3,22928,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,22928,1,3,0)
+42 ;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
+43 ;;^UTILITY(U,$J,358.3,22928,1,4,0)
+44 ;;=4^C85.15
+45 ;;^UTILITY(U,$J,358.3,22928,2)
+46 ;;=^5001706
+47 ;;^UTILITY(U,$J,358.3,22929,0)
+48 ;;=C85.18^^76^987^8
+49 ;;^UTILITY(U,$J,358.3,22929,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,22929,1,3,0)
+52 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
+53 ;;^UTILITY(U,$J,358.3,22929,1,4,0)
+54 ;;=4^C85.18
+55 ;;^UTILITY(U,$J,358.3,22929,2)
+56 ;;=^5001709
+57 ;;^UTILITY(U,$J,358.3,22930,0)
+58 ;;=C85.17^^76^987^9
+59 ;;^UTILITY(U,$J,358.3,22930,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,22930,1,3,0)
+62 ;;=3^B-Cell Lymphoma,Unspec,Spleen
+63 ;;^UTILITY(U,$J,358.3,22930,1,4,0)
+64 ;;=4^C85.17
+65 ;;^UTILITY(U,$J,358.3,22930,2)
+66 ;;=^5001708
+67 ;;^UTILITY(U,$J,358.3,22931,0)
+68 ;;=C85.10^^76^987^10
+69 ;;^UTILITY(U,$J,358.3,22931,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,22931,1,3,0)
+72 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
+73 ;;^UTILITY(U,$J,358.3,22931,1,4,0)
+74 ;;=4^C85.10
+75 ;;^UTILITY(U,$J,358.3,22931,2)
+76 ;;=^5001701
+77 ;;^UTILITY(U,$J,358.3,22932,0)
+78 ;;=L60.1^^76^988^2
+79 ;;^UTILITY(U,$J,358.3,22932,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,22932,1,3,0)
+82 ;;=3^Onycholysis
+83 ;;^UTILITY(U,$J,358.3,22932,1,4,0)
+84 ;;=4^L60.1
+85 ;;^UTILITY(U,$J,358.3,22932,2)
+86 ;;=^186837
+87 ;;^UTILITY(U,$J,358.3,22933,0)
+88 ;;=L60.2^^76^988^1
+89 ;;^UTILITY(U,$J,358.3,22933,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,22933,1,3,0)
+92 ;;=3^Onychogryphosis
+93 ;;^UTILITY(U,$J,358.3,22933,1,4,0)
+94 ;;=4^L60.2
+95 ;;^UTILITY(U,$J,358.3,22933,2)
+96 ;;=^5009235
+97 ;;^UTILITY(U,$J,358.3,22934,0)
+98 ;;=B35.1^^76^988^3
+99 ;;^UTILITY(U,$J,358.3,22934,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,22934,1,3,0)
+102 ;;=3^Onychomycosis
+103 ;;^UTILITY(U,$J,358.3,22934,1,4,0)
+104 ;;=4^B35.1
+105 ;;^UTILITY(U,$J,358.3,22934,2)
+106 ;;=^119748
+107 ;;^UTILITY(U,$J,358.3,22935,0)
+108 ;;=L60.3^^76^988^4
+109 ;;^UTILITY(U,$J,358.3,22935,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,22935,1,3,0)
+112 ;;=3^Onychorrexis/Onychodystrophy
+113 ;;^UTILITY(U,$J,358.3,22935,1,4,0)
+114 ;;=4^L60.3
+115 ;;^UTILITY(U,$J,358.3,22935,2)
+116 ;;=^5009236
+117 ;;^UTILITY(U,$J,358.3,22936,0)
+118 ;;=L50.8^^76^989^4
+119 ;;^UTILITY(U,$J,358.3,22936,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,22936,1,3,0)
+122 ;;=3^Urticaria,Other Spec
